Adc Therapeutics SA. (ADCT) NEW YORK STOCK EXCHANGE INC.

$5.45 0.34 (6.65%)

Market Cap: $419.17M

As of 02/01/23 04:00 PM EST. Market closed.

(ADCT)

Adc Therapeutics SA. (ADCT) NEW YORK STOCK EXCHANGE INC.

$5.45 0.34 (6.65%)

Market Cap: $419.17M

As of 02/01/23 04:00 PM EST. Market closed.

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of potent and targeted antibody drug conjugates (ADCs) for patients with hematological malignancies and solid tumors. The Company has created a deep clinical pipeline by combining its decades of experience and strategic target selection with proprietary ... read more

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of potent and targeted antibody drug conjugates (ADCs) for patients with hematological malignancies and solid tumors. The Company has created a deep clinical pipeline by combining its decades of experience and strategic target selection with proprietary next-generation pyrrolobenzodiazepine (PBD) technology. The Company's Biologics License Application for its lead product candidate, loncastuximab tesirine (Lonca, formerly ADCT-402) for the treatment of relapsed or refractory diffuse large B-cell lymphoma was given priority review status by the U.S. Food and Drug Administration and a Prescription Drug User Fee Act (PDUFA) target date of May 21, 2021. The Company's second lead product candidate, camidanlumab tesirine (Cami, formerly ADCT-301), is being evaluated in a 117-patient pivotal Phase 2 clinical trial for the treatment of relapsed or refractory Hodgkin lymphoma. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
312
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$5.11
Days Range
$5.04 - $5.49
52 week range
$2.69 - $17.89
Volume
498,581
Avg. Volume (30 days)
719,009
Market Cap
$419.17M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
76,911,712
Open
$0
Previous Close
$5.11
Days Range
$5.04 - $5.49
52 week range
$2.69 - $17.89
Volume
498,581
Avg. Volume (30 days)
719,009
Market Cap
$419.17M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
76,911,712

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ADC THERAPEUTICS SA
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
OWEN LAURA N VP, HR Dec 08, 2010 Option Exercise $12.75 9,437 120,322 0 Dec 09, 2010, 01:23 PM
OWEN LAURA N VP, HR Dec 08, 2010 Option Exercise $12.75 43,256 551,514 0 Dec 09, 2010, 01:23 PM
Jurasek Christopher VP, President APS, CIO Dec 08, 2010 Option Exercise $12.75 18,204 232,101 0 Dec 09, 2010, 01:10 PM
BOYLE JOHN J III Director Dec 08, 2010 Option Exercise $12.75 12,473 159,031 0 Dec 09, 2010, 01:09 PM
FORET MICKEY P Director Dec 08, 2010 Option Exercise $12.75 20,000 255,000 0 Dec 09, 2010, 01:07 PM
MARTIN LOIS M Director Dec 08, 2010 Option Exercise $12.75 1,000 12,750 0 Dec 09, 2010, 01:06 PM
Rehfeld John E Director Dec 08, 2010 Option Exercise $12.75 1,000 12,750 0 Dec 09, 2010, 01:05 PM
WANGBERG LARRY W Director Dec 08, 2010 Option Exercise $12.75 714 9,104 0 Dec 09, 2010, 01:03 PM
WUNSCH JOHN D Director Dec 08, 2010 Option Exercise $12.75 4,857 61,927 0 Dec 09, 2010, 01:02 PM
WUNSCH JOHN D Director Dec 08, 2010 Option Exercise $12.75 1,285 16,384 0 Dec 09, 2010, 01:02 PM
WUNSCH JOHN D Director Dec 08, 2010 Option Exercise $12.75 677 8,632 0 Dec 09, 2010, 01:02 PM
Hartwell Kimberly Seymour VP, Global GTM Dec 08, 2010 Option Exercise $12.75 15,827 201,794 0 Dec 09, 2010, 01:01 PM
MATHEWS JAMES G VP, CFO Dec 08, 2010 Option Exercise $12.75 2,880 36,720 0 Dec 09, 2010, 12:59 PM
MATHEWS JAMES G VP, CFO Dec 08, 2010 Option Exercise $12.75 25,728 328,032 0 Dec 09, 2010, 12:59 PM
Nemitz Steven Gary VP, Controller Dec 08, 2010 Option Exercise $12.75 242 3,086 0 Dec 09, 2010, 12:58 PM
Nemitz Steven Gary VP, Controller Dec 08, 2010 Option Exercise $12.75 2,476 31,569 0 Dec 09, 2010, 12:58 PM
OBRIEN PATRICK D VP, President GCS Dec 08, 2010 Option Exercise $12.75 5,300 67,575 0 Dec 09, 2010, 12:57 PM
OBRIEN PATRICK D VP, President GCS Dec 08, 2010 Option Exercise $12.75 48,637 620,122 0 Dec 09, 2010, 12:57 PM
Parran Richard B JR VP, President NS Dec 08, 2010 Option Exercise $12.75 20,522 261,656 0 Dec 09, 2010, 12:54 PM
PFLAUM JEFFREY D VP, GC & Secretary Dec 08, 2010 Option Exercise $12.75 3,535 45,071 0 Dec 09, 2010, 12:53 PM
PFLAUM JEFFREY D VP, GC & Secretary Dec 08, 2010 Option Exercise $12.75 37,578 479,120 0 Dec 09, 2010, 12:53 PM
SWITZ ROBERT E President & CEO Dec 08, 2010 Option Exercise $12.75 373,119 4,757,267 0 Dec 09, 2010, 12:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
OWEN LAURA N VP, HR 12/08/2010 120,322
OWEN LAURA N VP, HR 12/08/2010 551,514
Jurasek Christopher VP, President APS, CIO 12/08/2010 232,101
BOYLE JOHN J III Director 12/08/2010 159,031
FORET MICKEY P Director 12/08/2010 255,000
MARTIN LOIS M Director 12/08/2010 12,750
Rehfeld John E Director 12/08/2010 12,750
WANGBERG LARRY W Director 12/08/2010 9,104
WUNSCH JOHN D Director 12/08/2010 61,927
WUNSCH JOHN D Director 12/08/2010 16,384
WUNSCH JOHN D Director 12/08/2010 8,632
Hartwell Kimberly Seymour VP, Global GTM 12/08/2010 201,794
MATHEWS JAMES G VP, CFO 12/08/2010 36,720
MATHEWS JAMES G VP, CFO 12/08/2010 328,032
Nemitz Steven Gary VP, Controller 12/08/2010 3,086
Nemitz Steven Gary VP, Controller 12/08/2010 31,569
OBRIEN PATRICK D VP, President GCS 12/08/2010 67,575
OBRIEN PATRICK D VP, President GCS 12/08/2010 620,122
Parran Richard B JR VP, President NS 12/08/2010 261,656
PFLAUM JEFFREY D VP, GC & Secretary 12/08/2010 45,071
PFLAUM JEFFREY D VP, GC & Secretary 12/08/2010 479,120
SWITZ ROBERT E President & CEO 12/08/2010 4,757,267
Load More Insider Transactions